These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 1731102

  • 1. Human immunodeficiency virus type 1 and type 2 protease monomers are functionally interchangeable in the dimeric enzymes.
    Patterson CE, Seetharam R, Kettner CA, Cheng YS.
    J Virol; 1992 Feb; 66(2):1228-31. PubMed ID: 1731102
    [Abstract] [Full Text] [Related]

  • 2. Regulation of autoproteolysis of the HIV-1 and HIV-2 proteases with engineered amino acid substitutions.
    Rosé JR, Salto R, Craik CS.
    J Biol Chem; 1993 Jun 05; 268(16):11939-45. PubMed ID: 8505318
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins.
    Tözsér J, Bláha I, Copeland TD, Wondrak EM, Oroszlan S.
    FEBS Lett; 1991 Apr 09; 281(1-2):77-80. PubMed ID: 2015912
    [Abstract] [Full Text] [Related]

  • 5. Characterization of an active single polypeptide form of the human immunodeficiency virus type 1 protease.
    DiIanni CL, Davis LJ, Holloway MK, Herber WK, Darke PL, Kohl NE, Dixon RA.
    J Biol Chem; 1990 Oct 05; 265(28):17348-54. PubMed ID: 2211628
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
    Wu X, Liu H, Xiao H, Kappes JC.
    Virology; 1996 May 01; 219(1):307-13. PubMed ID: 8623547
    [Abstract] [Full Text] [Related]

  • 8. Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.
    Tomasselli AG, Hui JO, Sawyer TK, Staples DJ, Bannow C, Reardon IM, Howe WJ, DeCamp DL, Craik CS, Heinrikson RL.
    J Biol Chem; 1990 Aug 25; 265(24):14675-83. PubMed ID: 2201691
    [Abstract] [Full Text] [Related]

  • 9. Interactions of substrates and inhibitors with a family of tethered HIV-1 and HIV-2 homo- and heterodimeric proteinases.
    Griffiths JT, Tomchak LA, Mills JS, Graves MC, Cook ND, Dunn BM, Kay J.
    J Biol Chem; 1994 Feb 18; 269(7):4787-93. PubMed ID: 8106448
    [Abstract] [Full Text] [Related]

  • 10. Cloning, expression and purification of a recombinant poly-histidine-linked HIV-1 protease.
    Leuthardt A, Roesel JL.
    FEBS Lett; 1993 Jul 12; 326(1-3):275-80. PubMed ID: 8325379
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Site-directed mutagenesis of HIV-1 protease: generation of mutant proteases with increased stability to autodigestion.
    Tomasselli AG, Mildner AM, Rothrock DJ, Sarcich JL, Lull J, Leone J, Heinrikson R.
    Adv Exp Med Biol; 1995 Jul 12; 362():473-7. PubMed ID: 8540360
    [No Abstract] [Full Text] [Related]

  • 15. HIV-1 protease variants from 100-fold drug resistant clinical isolates: expression, purification, and crystallization.
    Vickrey JF, Logsdon BC, Proteasa G, Palmer S, Winters MA, Merigan TC, Kovari LC.
    Protein Expr Purif; 2003 Mar 12; 28(1):165-72. PubMed ID: 12651121
    [Abstract] [Full Text] [Related]

  • 16. A side chain at position 48 of the human immunodeficiency virus type-1 protease flap provides an additional specificity determinant.
    Moody MD, Pettit SC, Shao W, Everitt L, Loeb DD, Hutchison CA, Swanstrom R.
    Virology; 1995 Mar 10; 207(2):475-85. PubMed ID: 7886951
    [Abstract] [Full Text] [Related]

  • 17. Autoprocessing of the HIV-1 protease using purified wild-type and mutated fusion proteins expressed at high levels in Escherichia coli.
    Louis JM, McDonald RA, Nashed NT, Wondrak EM, Jerina DM, Oroszlan S, Mora PT.
    Eur J Biochem; 1991 Jul 15; 199(2):361-9. PubMed ID: 2070793
    [Abstract] [Full Text] [Related]

  • 18. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
    Barrie KA, Perez EE, Lamers SL, Farmerie WG, Dunn BM, Sleasman JW, Goodenow MM.
    Virology; 1996 May 15; 219(2):407-16. PubMed ID: 8638406
    [Abstract] [Full Text] [Related]

  • 19. Human immunodeficiency virus type 1 gag-protease fusion proteins are enzymatically active.
    Kotler M, Arad G, Hughes SH.
    J Virol; 1992 Nov 15; 66(11):6781-3. PubMed ID: 1404618
    [Abstract] [Full Text] [Related]

  • 20. Stability and activity of human immunodeficiency virus protease: comparison of the natural dimer with a homologous, single-chain tethered dimer.
    Cheng YS, Yin FH, Foundling S, Blomstrom D, Kettner CA.
    Proc Natl Acad Sci U S A; 1990 Dec 15; 87(24):9660-4. PubMed ID: 2263618
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.